Windlas Biotech MD, chairman, board of directors and AGM
NSE: WINDLASBSE: 543329Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹900.40.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,801 Cr1,237th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 27.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Jul 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.72%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Jul 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 92,52449.2% delivered
Windlas Biotech board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonVIVEK DHARIWAL
- Company Secretary and Compliance OfficerAnanta Narayan Panda
8 directors3 independent4 executive1 non-executive
- VIVEK DHARIWAL · ChairpersonIndependent · joined May 2021 · reappointed May 2026 · 65 months as independent · 1 listed board · 1 as independent
- ASHOK KUMAR WINDLASSExecutive · joined Feb 2001 · reappointed May 2026 · 1 listed board
- HITESH WINDLASSExecutive · joined Jan 2008 · reappointed Apr 2025 · 1 listed board · 1 committee seat
- MANOJ KUMAR WINDLASSExecutive · joined Apr 2006 · reappointed Apr 2025 · 1 listed board · 1 committee seat
- PAWAN KUMAR SHARMAExecutive · joined Jun 2019 · reappointed Jun 2024 · 1 listed board
- GAURAV GULATIIndependent · joined May 2021 · reappointed May 2026 · 65 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- PRACHI JAIN WINDLASSNon-executive · joined May 2021 · reappointed May 2021 · 1 listed board · 1 committee seat
- TARASHREE SINGHALIndependent · joined May 2026 · reappointed May 2026 · 5 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- SRINIVASAN VENKATARAMAN, left 6 May 2026: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 10 Aug 20267 of 8 present2 independent · 80 days in between
- 21 May 20267 of 8 present3 independent
Audit Committee
Chair GAURAV GULATI
HITESH WINDLASS, TARASHREE SINGHAL
- 10 Aug 20263 of 3 present2 independent · 80 days in between
- 21 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair GAURAV GULATI
VIVEK DHARIWAL, TARASHREE SINGHAL
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair GAURAV GULATI
PRACHI JAIN WINDLASS, MANOJ KUMAR WINDLASS
- 10 Aug 20263 of 3 present1 independent · 80 days in between
- 21 May 20262 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- J.C. Bhalla & Co.Peer-review certificate valid to Dec 2027
1 earlier auditor
- S S Kothari Mehta & Co LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Windlas Biotech AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Windlas Biotech dividend history
Annual general meeting, 23 Jul 2026
45,932 shareholders on the register on 16 Jul 2026; present: 7 promoters and 57 others; votes counted by Sandeep Joshi / Sandeep Joshi & Associates.The company's voting result (opens in a new tab)
Approval and adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Auditors and the Board of Directors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
- Declaration of Final Dividend of Rs. 6.30/- per Equity Share for the financial year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
- Appointment of a Director in place of Mr. Hitesh Windlass, Managing Director (DIN:02030941),who is liable to retire by rotation and being eligible, offers himself for re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
- Appointment of a Director in place of Mrs. Prachi Jain Windlass, Director (DIN:06661073),who is liable to retire by rotation and being eligible, offers herself for re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
- Ratification of the remuneration of the Cost AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
- Appointment of Dr. Tarashree Singhal (DIN:11697518) as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.39% · promoters 100.00% · institutions 63.10% · other public 2.81%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 19 Mar 2026, 3 resolutions
45,610 shareholders on the register on 13 Feb 2026; votes counted by Sandeep Joshi / Sandeep Joshi & Associates.The company's voting result (opens in a new tab)
- Re-appointment of Mr. Ashok Kumar Windlass as Wholetime DirectorSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.69% · promoters 100.00% · institutions 83.82% · other public 1.77%
- Re-appointment of Mr. Vivek Dhariwal as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.69% · promoters 100.00% · institutions 83.82% · other public 1.77%
- Re-appointment of Mr. Gaurav Gulati as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.69% · promoters 100.00% · institutions 83.82% · other public 1.77%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 28 Jul 2025, 9 resolutions
45,758 shareholders on the register on 21 Jul 2025; present: 7 promoters and 48 others; votes counted by Sandeep Joshi / Sandeep Joshi & Associates.The company's voting result (opens in a new tab)
Approval and adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the Reports of the Auditors and the Board of Directors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Declaration of Final Dividend of Rs. 5.80/- per Equity Share for the financial year 2024-25Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Appointment of a Director in place of Mr. Pawan Kumar Sharma, Executive Director (DIN: 08478261),who is liable to retire by rotation and being eligible, offers himself for re-appointmentOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
Appointment of M/s J C Bhalla & Co., Chartered Accountants (Firm Registration Number: 001111N) as Statutory Auditors of the Company in place of M/s S S Kothari Mehta & Co. LLP, Chartered Accountants, (Firm’s Regn. No. 000756N/ N500441) and fix their remunerationMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Ratification of the remuneration of the Cost AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Appointment of M/s Sandeep Joshi & Associates, Practicing Company Secretary (COP No. 19210) as Secretarial Auditors of the Company for a period of 5 yearsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Approval of the ‘Windlas Plan 2025’Special94.13% for5.87% against
Against: promoters 0.00% · institutions 41.30% · other public 15.62%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Approval of grant of Units to the eligible employees of the subsidiary company(ies) of the Company under ‘Windlas Plan 2025’ (“Plan”)Special94.13% for5.87% against
Against: promoters 0.00% · institutions 41.30% · other public 15.62%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
- Approval of grant of Units equal or more than 1% of Issued Capital to the identified employeesSpecial94.13% for5.87% against
Against: promoters 0.00% · institutions 41.30% · other public 15.62%
Turnout: all 73.12% · promoters 100.00% · institutions 79.07% · other public 2.46%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 22 Mar 2025, 2 resolutions
47,166 shareholders on the register on 14 Feb 2025; votes counted by Sandeep Joshi / Sandeep Joshi & Associates.The company's voting result (opens in a new tab)
- Re-appointment of Mr. Hitesh Windlass as Managing DirectorOrdinaryPromoters have an interest in it99.94% for0.06% against
Against: promoters 0.00% · institutions 0.56% · other public 0.00%
Turnout: all 70.79% · promoters 100.00% · institutions 65.74% · other public 1.56%
- Re-appointment of Mr. Manoj Kumar Windlass as Joint Managing DirectorOrdinaryPromoters have an interest in it98.82% for1.18% against
Against: promoters 0.00% · institutions 10.38% · other public 0.00%
Turnout: all 70.79% · promoters 100.00% · institutions 65.74% · other public 1.56%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 24 Sep 2024, 4 resolutions
Present: 7 promoters and 58 others.The company's voting result (opens in a new tab)
- Adoption of standalone and consolidated financial statements for the financial year ended 31 March 2024Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.80% · promoters 100.00% · institutions 78.70% · other public 0.94%
- Approval of final dividend of Rs. 5.50/- per Equity share for the financial year 2023-24Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.80% · promoters 100.00% · institutions 78.70% · other public 0.94%
- Reappointment of Mr. Manoj Kumar Windlass (DIN: 00221671) as Director, liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.80% · promoters 100.00% · institutions 78.70% · other public 0.94%
- Ratification of remuneration of the Cost AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 71.80% · promoters 100.00% · institutions 78.70% · other public 0.94%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 2 Aug 2024, 1 resolution
The company's voting result (opens in a new tab)
- Approval for re-appointment of Mr. Pawan Kumar Sharma as an Executive DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.25%
Turnout: all 72.48% · promoters 100.00% · institutions 81.41% · other public 0.99%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 12 Sep 2023, 7 resolutions
Present: 7 promoters and 49 others.The company's voting result (opens in a new tab)
- Adoption of standalone and consolidated financial statements for the financial year ended 31 March 2023Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Approval of final dividend of Rs. 4.0 per equity share for the financial year 2022-23Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Reappointment of Mr. Hitesh Windlass (DIN: 02030941) as Director, liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Reappointment of Ms. Prachi Jain Windlass (DIN: 06661073) as Director, liable to retire by rotationOrdinary98.96% for1.04% against
Against: promoters 0.00% · institutions 6.87% · other public 0.03%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Ratification of the remuneration of the Cost AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Approval of the ‘WBL Employee Stock Option Scheme 2023’Special98.97% for1.03% against
Against: promoters 0.00% · institutions 6.86% · other public 0.00%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
- Approval of grant of employee stock option equal or more than 1% of the Issued Capital to the Identified EmployeesSpecial98.96% for1.04% against
Against: promoters 0.00% · institutions 6.86% · other public 0.60%
Turnout: all 74.45% · promoters 100.00% · institutions 91.09% · other public 1.66%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 19 Sep 2022, 4 resolutions
Present: 7 promoters and 37 others.The company's voting result (opens in a new tab)
Adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Auditors and the Board of Directors’ thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.22% · promoters 100.00% · institutions 95.34% · other public 0.05%
- Declaration of Final Dividend of Rs. 3.50/- per Equity Share for the financial year 2021-22Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 73.22% · promoters 100.00% · institutions 95.34% · other public 0.05%
- Re-appointment of Mr. Manoj Kumar Windlass, Joint Managing Director who is liable to retire by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 3.34%
Turnout: all 73.22% · promoters 100.00% · institutions 95.34% · other public 0.05%
- Ratification of remuneration of Cost AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 16.02%
Turnout: all 73.22% · promoters 100.00% · institutions 95.34% · other public 0.05%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 23 Jul 2026, 1 fund house so far (houses' deadline to file 15 Oct 2026)
Approval and adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Auditors and the Board of Directors thereonMoreLess
1 for0 against- Declaration of Final Dividend of Rs. 6.30/- per Equity Share for the financial year 2025-261 for0 against
- Appointment of a Director in place of Mr. Hitesh Windlass, Managing Director (DIN:02030941),who is liable to retire by rotation and being eligible, offers himself for re-appointment1 for0 against
- Appointment of a Director in place of Mrs. Prachi Jain Windlass, Director (DIN:06661073),who is liable to retire by rotation and being eligible, offers herself for re-appointment1 for0 against
- Ratification of the remuneration of the Cost Auditor1 for0 against
- Appointment of Dr. Tarashree Singhal (DIN:11697518) as an Independent Director1 for0 against
Mutual fund votes, meeting of 19 Mar 2026, 4 fund houses
- Re-appointment of Mr. Ashok Kumar Windlass as Wholetime Director4 for0 against
- Re-appointment of Mr. Vivek Dhariwal as an Independent Director4 for0 against
- Re-appointment of Mr. Gaurav Gulati as an Independent Director4 for0 against
6 earlier meetings
Mutual fund votes, meeting of 28 Jul 2025, 4 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
Approval and adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with the Reports of the Auditors and the Board of Directors thereonMoreLess
4 for0 against- Declaration of Final Dividend of Rs. 5.80/- per Equity Share for the financial year 2024-254 for0 against
- Appointment of a Director in place of Mr. Pawan Kumar Sharma, Executive Director (DIN: 08478261),who is liable to retire by rotation and being eligible, offers himself for re-appointment4 for0 against
Appointment of M/s J C Bhalla & Co., Chartered Accountants (Firm Registration Number: 001111N) as Statutory Auditors of the Company in place of M/s S S Kothari Mehta & Co. LLP, Chartered Accountants, (Firm’s Regn. No. 000756N/ N500441) and fix their remunerationMoreLess
4 for0 against- Ratification of the remuneration of the Cost Auditor4 for0 against
- Appointment of M/s Sandeep Joshi & Associates, Practicing Company Secretary (COP No. 19210) as Secretarial Auditors of the Company for a period of 5 years4 for0 against
- Approval of the ‘Windlas Plan 2025’
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Excessive potential benefit may be extended to an individual employee under the proposed Plan 2025.
1 for2 against - Approval of grant of Units to the eligible employees of the subsidiary company(ies) of the Company under ‘Windlas Plan 2025’ (“Plan”)
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, UTI Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Excessive potential benefit may be extended to an individual employee under the proposed Plan 2025.
- UTI Mutual FundOur views on this resolution are linked to our views on resolution #7. We do not support the resolution.
1 for3 against - Approval of grant of Units equal or more than 1% of Issued Capital to the identified employees
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, UTI Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance & Transparency Concern: Excessive potential benefit may be granted and inadequate justification has been provided for the proposed grant.
- UTI Mutual FundThe company, through a separate resolution, proposes to grant stock options to Ms. Komal Gupta – Chief Executive Officer and Chief Financial Officer – upto 315,000 options, in excess of 1% of the issued capital. We do not support grant of stock options exceeding 1% of the paid-up share capital without a clear rationale for the grant. In this case, Komal Gupta is eligible for over 50% of the option pool – skewing the distribution of options towards a single employee. Further, our views on this resolution are linked to our views on Resolution #6. We do not support the resolution.
1 for3 against
1 proposal not matched to one resolution
- Approve the Windlas Plan 2025 under which an aggregate up to 590,250 restricted stock units and performance stock units can be granted
Against UTI Mutual Fund
- UTI Mutual FundAt a significant discount to the market price as well as non clarity of pre-defined performance parameters
0 for1 against
Mutual fund votes, meeting of 22 Mar 2025, 4 fund houses
- Re-appointment of Mr. Hitesh Windlass as Managing Director
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundRe-appointment compliant with law. Governance Concern: Skewed Remuneration in favour of promoters. No absolute cap on variable pay.
2 for2 against - Re-appointment of Mr. Manoj Kumar Windlass as Joint Managing Director
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, UTI Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundRe-appointment compliant with law. Governance Concern: Skewed Remuneration in favour of promoters. No absolute cap on variable pay.
- UTI Mutual FundManoj Kumar Windlass’s FY24 remuneration aggregated Rs. 17.5 mn. As per his previous terms, we estimate his FY25 remuneration at Rs. 20.5 mn (including commission at 1.5% of net profits). As per his proposed terms, we estimate his FY26 remuneration at Rs. 42.9 mn (including commission at 2.0% of net profits). The company should cap the commission in absolute amounts and disclose the performance metrics which determine such variable pay. While we support his reappointment as Joint MD, we do not support the resolution as the estimated promoter and promoter family remuneration is high for the size and complexity of the business and not in line with peers.
1 for3 against
Mutual fund votes, meeting of 24 Sep 2024, 1 fund house
- Adoption of standalone and consolidated financial statements for the financial year ended 31 March 20241 for0 against
- Approval of final dividend of Rs. 5.50/- per Equity share for the financial year 2023-241 for0 against
- Reappointment of Mr. Manoj Kumar Windlass (DIN: 00221671) as Director, liable to retire by rotation1 for0 against
- Ratification of remuneration of the Cost Auditor1 for0 against
Mutual fund votes, meeting of 2 Aug 2024, 1 fund house
- Approval for re-appointment of Mr. Pawan Kumar Sharma as an Executive Director1 for0 against
Mutual fund votes, meeting of 12 Sep 2023, 2 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- Adoption of standalone and consolidated financial statements for the financial year ended 31 March 20232 for0 against
- Approval of final dividend of Rs. 4.0 per equity share for the financial year 2022-232 for0 against
- Reappointment of Mr. Hitesh Windlass (DIN: 02030941) as Director, liable to retire by rotation
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundRe-appointment compliant with law. Governance Concern: Skewed Remuneration in favour of promoters.
1 for1 against - Reappointment of Ms. Prachi Jain Windlass (DIN: 06661073) as Director, liable to retire by rotation
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundRe-appointment compliant with law. Governance Concern: Low Attendance and no justification provided.
1 for1 against - Ratification of the remuneration of the Cost Auditor2 for0 against
- Approval of the ‘WBL Employee Stock Option Scheme 2023’2 for0 against
1 proposal not matched to one resolution
To create, offer and grant from time to time such number of employee stock options (Options) to each of the proposed Option grantees, whether existing or joining in future subject to their joining under the WBL Employee Stock Option Scheme 2023 (ESOS 2023 or Scheme), exercisable into equal number of equity shares of face value of Rs 5/- each fully paid up in the Company, which may individually be equal to or exceed 1% of the issued capital (excluding outstanding warrants and conversions) of the Company at the time of grant of Options to Ms. Komal Gupta, Chief Executive Officer cum Chief Financial Officer of the Company.MoreLess
2 for0 against
Mutual fund votes, meeting of 19 Sep 2022, 2 fund houses
Adoption of the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Auditors and the Board of Directors’ thereon.MoreLess
2 for0 against- Declaration of Final Dividend of Rs. 3.50/- per Equity Share for the financial year 2021-222 for0 against
- Re-appointment of Mr. Manoj Kumar Windlass, Joint Managing Director who is liable to retire by rotation and being eligible, offers himself for re-appointment.2 for0 against
- Ratification of remuneration of Cost Auditor2 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.